EUVIMEDEUVIMED entdecken
Open Access

Patient‐Derived Organoid and Single‐Cell Multiomics Reveal Evolution Driven by CEACAM6 / KRT19 ‐Mediated Heterogeneity

Changwen Jing iD, Zhuo Wang, Haixia Cao, Yuan Zhang, Yuchun Huang, Yuetong Yu, Bingzhe Li, Rong Ma

The FASEB Journal · 2026

DOI: 10.1096/fj.202600610r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Changwen Jing und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Pathology Laboratory, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & the Affiliated Cancer Hospital of Nanjing Medical Un…. Hauptthemen laut MEDLINE: Cell Adhesion Molecules, Organoids, Colorectal Neoplasms, Antigens, CD. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), JST | Jiangsu Provincial Key Research and Development Program (Key Technologies R&D Program of Jiangsu Province), Ministry of Health of China | Wu Jieping Medical Foundation (WJMF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) remains a leading cause of cancer mortality globally, with therapeutic efficacy hindered by tumor heterogeneity and drug resistance. While organoid technology offers unprecedented opportunities to model tumor complexity, systematic platforms for chemo‐targeted combination screening and molecular mechanisms underlying chemoresistance remain underexplored in Chinese populations. Here, we established a biobank of 17 patient‐derived CRC organoids (85% success rate) from treatment‐naïve surgical specimens, preserving histopathological fidelity and molecular diversity of parental tumors. High‐throughput drug screening across eight clinical regimens revealed different responses. To dissect chemoresistance mechanisms, six organoids representing extreme phenotypes (three sensitive and three resistant, based on IC50 difference for irinotecan + raltitrexed) were selected from this cohort for single‐cell transcriptomic analysis. Single‐cell transcriptomics of irinotecan + raltitrexed‐treated organoids identified chemoresistance‐associated clonal expansion of epithelial subpopulations (cluster_0), characterized by overexpression of REG4/TFF1/TFF3 and epithelial keratins (KRT19/KRT8/KRT18). Intercellular network analysis revealed intra‐epithelial communication as a resistance hub, mediated by 32 ligand‐receptor pairs. Integration with TCGA‐COAD cohort ( n = 378) demonstrated intratumoral heterogeneity (ITH) score as an independent prognostic determinant, outperforming stemness/angiogenesis metrics. Machine learning consensus identified CEACAM6 and KRT19 as dual regulators of mortality and ITH through epithelial plasticity networks. Our multi‐omics framework establishes organoid‐guided chemoresistance mechanisms while proposing ITH quantification targeting as precision strategies. This study bridges critical gaps in CRC therapeutic personalization, offering clinically actionable insights for overcoming treatment failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Adhesion MoleculesOrganoidsColorectal NeoplasmsAntigens, CDHumansDrug Resistance, NeoplasmMultiomicsGPI-Linked ProteinsIrinotecanSingle-Cell AnalysisQuinazolinesFemaleKeratin-19

Stichwörter der Autor:innen

CEACAM6CRCITHKRT19resistancesingle‐cell sequencing

Substanzen

Cell Adhesion MoleculesCEACAM6 protein, humanGPI-Linked ProteinsKRT19 protein, humanAntigens, CDIrinotecanQuinazolinesKeratin-19

Autor:innen und Institutionen

  • Molecular Pathology Laboratory, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
  • Science and Technology Department, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research & the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
  • College of Public Health, Medical University, Nanjing, China.
  • Yangzhou University Medical College, Yangzhou, China.

ORCID-Profile: Changwen Jing

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • JST | Jiangsu Provincial Key Research and Development Program (Key Technologies R&D Program of Jiangsu Province)
  • Ministry of Health of China | Wu Jieping Medical Foundation (WJMF)
  • National Natural Science Foundation of China
  • Jiangsu Provincial Key Research and Development Program
  • Wu Jieping Medical Foundation

Zitieren

APA

Jing, C., Wang, Z., Cao, H., Zhang, Y., Huang, Y., Yu, Y., Li, B., & Ma, R. (2026). Patient‐Derived Organoid and Single‐Cell Multiomics Reveal Evolution Driven by CEACAM6 / KRT19 ‐Mediated Heterogeneity. The FASEB Journal. https://doi.org/10.1096/fj.202600610r

Vancouver

Jing C, Wang Z, Cao H, Zhang Y, Huang Y, Yu Y, et al. Patient‐Derived Organoid and Single‐Cell Multiomics Reveal Evolution Driven by CEACAM6 / KRT19 ‐Mediated Heterogeneity. The FASEB Journal. 2026. doi:10.1096/fj.202600610r

BibTeX
@article{Jing2026,
  author = {Jing, Changwen and Wang, Zhuo and Cao, Haixia and Zhang, Yuan and Huang, Yuchun and Yu, Yuetong and Li, Bingzhe and Ma, Rong},
  title = {Patient‐Derived Organoid and Single‐Cell Multiomics Reveal Evolution Driven by CEACAM6 / KRT19 ‐Mediated Heterogeneity},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202600610r}
}
Kostenlos starten →